Article
DOPA-sensitive dystonia-plus syndrome.
Developmental medicine and child neurology - 1 Mar 2005
Casseron Wilfrid, Genton Pierre
Abstract excerpt
We report on two sisters with a childhood-onset form of predominantly axial dystonia with marked diurnal fluctuations. Onset of clinical features was at approximately 6 years of age. Associated features included marked fatigue, slight facial dysmorphism, short stature, obesity, and learning disability*. Dystonia and fatigue responded to 3,4-dihydroxyphenylalanine (DOPA) therapy, with recurrence of symptoms upon...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
